Annual New England TB Clinician's Conference

Date: October 27, 2021
Location: Virtual

The purpose of this training is to strengthen providers’ knowledge of TB diagnosis, treatment, and management. This conference will provide an opportunity to address current and emerging issues in TB. Topics will include a review of what’s new in TB, the importance of testing and treating LTBI in primary care settings, and current treatment modalities for drug-resistant TB.

This conference is primarily designed for healthcare providers who are involved in the diagnosis, treatment, and management of persons with latent TB infection and disease. The content will be applicable for physicians, physician assistants, nurse practitioners, fellows, and residents. Public health nurses and others working in TB control are welcome to attend.

As the incidence of tuberculosis continues to decline, maintaining clinical and public health expertise in TB is particularly challenging. Therefore, ongoing training and education are important for healthcare providers to enhance skills in TB diagnosis, follow recommended treatment guidelines, and interact effectively with public health agencies. This type of training is also important for new clinicians working in TB control or other settings.

Upon completion of this conference, participants should be better able to:

  • Use updated guidance to initiate appropriate patient-centered treatment and improve treatment outcomes for patients with TB.
  • Explain the rationale for increased focus on identifying and treating TB infection to sustain progress toward TB elimination in the US.
  • Outline current treatment regimens for drug-resistant tuberculosis.


In order to meet the learning objectives and receive continuing education credits, participants are required to attend the entire meeting, and complete an evaluation.

  • CONTINUING EDUCATION INFORMATION support of improving patient care, this activity has been planned and implemented by Rutgers Biomedical and Health Sciences and the New England TB Consortium. Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
    CME: Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
    CNE: This activity is awarded 3.25 contact hours (60 minute CH). Nurses should only claim those contact hours actually spent participating in the activity.

    All individuals who affect content of continuing education activities are required to disclose to the audience any real or apparent conflict of interest related to the activity. The activity faculty are further required to disclose discussion of off-label/investigational uses in their presentations. These disclosures will be made to the audience at the time of the activity.

    There is no charge to attend this webinar but pre-registration is mandatory: Virtual Conference Registration.

    There is limited space for the webinar and acceptance will be on a firstcome, first-serve basis. For additional information, please contact Olivia Dupont at

    Funding for this conference was made possible in part by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.

    If you require an accommodation because of a disability, or if you have any additional needs or other questions, please contact Anita Khilall at



    John Bernardo, MD
    Professor of Medicine & Research Professor of Biochemistry
    Boston University School of Medicine

    Pennan Barry, MD
    Assistant Clinical Professor
    University of California, San Francisco

    Robert Horsburgh, MD
    Professor of Medicine
    Boston University School of Medicine

    Dylan Tierney, MD
    Associate Medical Director, Bureau of Infectious Disease and Laboratory Sciences
    Massachusetts Department of Public Health

    Danielle Orcutt, MPH, RN
    Connecticut Department of Public Health

    Daria Szkwarko, DO, MPH
    Assistant Professor of Family Medicine
    Brown University

    Rebecca Thal, NP
    Family Medicine Nurse Pracitioner
    Family Health Center of Worcester

    Carlos Acuna-Villaorduna, MD
    Adjunct Assist Professor
    Boston University School of Medicine



    John Bernardo, MD
    Professor of Medicine & Research Professor of Biochemistry
    Boston University School of Medicine

    Jennifer Cochran, MPH

    Division of Global Populations and Infectious Disease Prevention
    Massachusetts Department of Public Health

    Olivia Dupont, MPH
    Health Educator

    Global Tuberculosis Institute

    Rosaura Garcia, CHES
    Health Educator

    Global Tuberculosis Institute

    Anna Hippchen, NP
    Nurse Pracitioner Specialist
    The Miriam Hospital

    Pat Iyer, MSN, RN, BC
    Director of Patient Management, TB Program
    Massachusetts Department of Public Health

    Anita Khilall, MPH - Activity Director
    Program Director, Education & Training
    Global Tuberculosis Institute

    Darlene Morse, RN, MSN
    Nurse Consultant
    New Hampshire Division of Public Health Services